BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And 9 Months Ended 31.12.2023.
1. Taken on record and approved the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter and 9 Months ended 31.12.2023. A copy of the approved financial results together with Limited Review Reports issued by the statutory auditors of the company with unmodified opinion is enclosed with this intimation. 2. The Board has considered and acknowledged the receipt of letter of allotment from KIADB allotting 5 acres of land to the company at Kadechur KIADB industrial area, Yadgiri, Karnataka. The proposed project for setting up of the API and Intermediaries manufacturing facility at the above said industrial are was approved at the State Level Single Window Clearance Committee, Government of Karnataka.12-02-2024